Company & Sponsor Intelligence

Rush University Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting2

Completed3

Countries1

Therapeutic footprint

autismepilepsyneurodevelopmental_otherparkinsons

Indexed studies

NCT03552484In-Home Care for Patients With PSP and Related Disorders
parkinsons · United StatesNA

NCT06139172Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
neurodevelopmental_other · United StatesNA

NCT02918864Oxytocin and Social Cognitive Skills Groups
autism · United StatesPHASE2

NCT01309074Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline
epilepsy · United StatesPHASE4

NCT03336697Determining the Microbiota Composition of the Middle Meatus in Parkinson's
parkinsons · United StatesCOMPLETED

NCT05114538Improving the Part C Early Intervention Service Delivery System for Children With ASD
autism · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →